572
Chem. Pharm. Bull.
Vol. 66, No. 5 (2018)
hexane/EtOAc (97:3) to afford 6 (477.9mg, 93%) as an oil; a solution of dimethylaminopyridine (DMAP) (48.4mg) in
1H-NMR (CDCl3) δ: −0.01 (9H, s), 1.32–1.41 (4H, m), 1.45 Et3N (8.7mL), and Ac2O (430µL) were mixed together at
(2H, brd, J=8.4Hz), 1.48–1.88 (8H, m), 1.95–2.02 (2H, m), r.t. After stirring for 1h, the mixture was extracted with
3.39 (1H, dt, J=9.5, 6.7Hz), 3.46–3.54 (1H, m), 3.73 (1H, dt, AcOEt/1 M HCl aq. The organic layer was washed with
J=9.5, 6.9Hz), 3.83–3.90 (1H, m), 4.57 (1H, dd, J=4.3, 2.7Hz), 1M HCl aq. and dried. Evaporation of the solvent followed
5.21–5.29 (1H, m), 5.33–5.42 (1H, m); 13C-NMR (CDCl3) δ: by silica gel (25g) column chromatography using hexane/
−1.8 (3C), 18.4, 19.7, 25.5, 26.0, 27.0, 29.6, 29.7, 30.8, 62.3, EtOAc (95:5) as the eluent afforded 12 (1225.2mg, 91%) as
1
67.6, 98.8, 125.4, 127.5; IR (neat/NaCl) cm−1: 1248, 858; MS an oil; H-NMR (CDCl3) δ: 0.00 (9H×1/3, s), 0.03 (9H×2/3,
(EI) m/z: 284 (M+, 5%), 85 (100), 73 (63); HR-EI-MS m/z: s), 1.33–1.87 (12H, m), 1.53 (2H×1/3, s), 1.54 (2H×2/3, s),
284.2173 (M+) (Calcd for C16H32O2Si: 284.2172).
1.93–2.11 (2H, m), 2.06 (3H×1/3, s), 2.07 (3H×2/3, s), 3.37
8-(Trimethylsilyl)oct-6-en-1-ol (7) H2O (3.8mL) and (1H×1/3, dt, J=9.4, 6.5Hz), 3.38 (1H×2/3, dt, J=9.4, 6.5Hz),
p-TsOH monohydrate (26.1mg) were added successively to a 3.46–3.53 (1H, m), 3.72 (1H×1/3, dt, J=9.4, 6.5Hz), 3.73
stirred solution of 6 (292.7mg, 1.03mmol) in MeOH (7.6mL), (1H×2/3, dt, J=9.4, 6.5Hz), 3.83–3.90 (1H, m), 4.40 (2H×2/3,
and the mixture was refluxed for 4h. After cooling to r.t., s), 4.51 (2H×1/3, s), 4.55–4.59 (1H, m), 5.24 (1H×1/3, t,
NaHCO3 aq. was added, and the mixture was extracted with J=7.4Hz), 5.32 (1H×2/3, t, J=6.9Hz); 13C-NMR (CDCl3) as-
EtOAc and dried. Evaporation of the solvent followed by silica signed for the Z-isomer δ: −0.7 (3C), 19.2, 19.7, 21.1, 25.5,
gel (5g) column chromatography using hexane/EtOAc (95:5) 26.1, 28.2, 29.3, 29.7, 30.8, 62.4, 63.4, 67.6, 98.9, 127.0, 131.8,
as the eluent afforded 735,42) (186.7mg, 91%).
171.0; assigned for the E-isomer δ: −1.3 (3C), 19.2, 19.7, 21.0,
8-(Trimethylsilyl)oct-6-enal (8) A solution of (COCl)2 25.0, 25.9, 27.8, 29.6, 30.0, 30.8, 62.3, 63.4, 67.5, 98.8, 129.0,
(260 µL) in CH2Cl2 (27mL) was cooled to −78°C, and a so- 131.2, 171.2; IR (neat/NaCl) cm−1: 1738, 1248, 851; MS (FAB)
lution of dimethylsulfoxide (0.3mL) in CH2Cl2 (1mL) was m/z: 357 ([M+H]+, 4%), 307 (15), 154 (62), 136 (49), 85 (100);
added. After stirring for 15min, a solution of 7 (272.4mg, HR-(FAB)-MS m/z: 357.2453 ([M+H]+) (Calcd for C19H37O4Si:
1.36mmol) in CH2Cl2 (4mL) was added, and stirring was 357.2461).
continued for an additional 30min. Et3N (1.2mL) was added,
8-Hydroxy-2-(trimethylsilylmethyl)oct-2-en-1-yl Acetate
and the mixture was stirred at r.t. for 2h. After the addition of (13) Pyridinium p-toluenesulfonate (86.9mg) was added
NH4Cl aq., the mixture was extracted with CH2Cl2 and dried. to a stirred solution of 12 (1225.3mg, 3.44mmol) in EtOH
Evaporation of the solvent afforded an oily residue, which (3.5mL), and the mixture was stirred at 55°C for 11h. An
was chromatographed on neutral alumina (30g, containing aqueous solution of NaHCO3 was added, and the aqueous
10% water) using hexane as the eluent to afford 835) (251.0mg, mixture was extracted with EtOAc, dried, and the solvent
93%).
2-Vinylcyclohexan-1-yl Benzoate (10)
was evaporated. The residual oil was subjected to silica gel
solution of (26g) column chromatography using hexane/EtOAc (78:22)
A
DBSA (54.8mg, 0.17mmol) in water (0.6mL) was prepared to afford 13 (748.4mg, 80%) as an oil; 1H-NMR (CDCl3)
at r.t. with stirring, and 8 (31.4mg, 0.16mmol) was dissolved δ: 0.00 (9H×1/3, s), 0.03 (9H×2/3, s), 1.33–1.61 (7H, m),
in this solution. After stirring at r.t. for 1d, NaHCO3 aq. 1.54 (2H×1/3, s), 1.55 (2H×2/3, s), 1.96–2.10 (2H, m), 2.07
was added, and the mixture was extracted with CH2Cl2 and (3H×1/3, s), 2.07 (3H×2/3, s), 3.63 (2H×1/3, t, J=6.6Hz),
dried. The solvent was evaporated off carefully, and the crude 3.64 (2H×2/3, t, J=6.6Hz), 4.40 (2H×2/3, s), 4.52 (2H×1/3,
product 9 was dissolved in CH2Cl2 (25mL). Pyridine (640µL) s), 5.23 (1H×1/3, t, J=7.5Hz), 5.32 (1H×2/3, t, J=6.9Hz);
and benzoyl chloride (925µL) were added successively with 13C-NMR (CDCl3) assigned for the Z-isomer δ: −0.7 (3C),
stirring, and stirring was continued for 2d. NH4Cl aq. was 19.2, 21.1, 25.5, 28.2, 29.2, 32.7, 62.9, 70.1, 126.8, 131.9, 171.0.
added, and the mixture was extracted with CH2Cl2 and dried. assigned for the E-isomer δ: −1.3 (3C), 19.2, 21.0, 25.2, 27.8,
Evaporation of the solvent followed by silica gel (55g) column 29.9, 32.6, 63.4, 70.1, 128.9, 131.4, 171.2; IR (neat/NaCl) cm−1:
chromatography using hexane/EtOAc (98:2) as the eluent af- 1738, 1248, 845; MS (EI) m/z: 272 (M+, 0.2%), 212 (27), 133
forded 1043) (27.0mg, 74%).
(59), 117 (100); HR-EI-MS m/z: 272.1801 (M+) (Calcd for
8-(Tetrahydro-2H-pyran-2-yl)oxy-2-(trimethylsilylmethyl)- C14H28O3Si: 272.1808).
oct-2-en-1-ol (11) DIBAL-H (12.0mL, 1.0M in toluene) was
8-Oxo-2-(trimethylsilylmethyl)oct-2-en-1-yl Acetate (14)
added to a stirred solution of 3 (1129.6mg, 3.17mmol) in dry Pyridine (0.39mL) and Dess–Martin periodinane (1047.2mg)
CH2Cl2 (60mL), and the solution was stirred at −50°C for 3d. were added successively to a stirred solution of 13 (312.1mg,
The reaction was quenched by the addition of MeOH, and a 1.147mmol) in CH2Cl2 (18mL) at r.t. After further stirring
saturated solution of Rochelle salt was added. The mixture for 15min, Na2SO3 aq. and NaHCO3 aq. were added, and the
was extracted with CH2Cl2, dried, and the solvent was evapo- mixture was extracted with CH2Cl2 and dried. Evaporation
rated off. The resultant residue was chromatographed on silica of the solvent followed by silica gel (27g) column chroma-
gel (27g) using hexane/EtOAc (83:17) as the eluent to afford tography using hexane/EtOAc (9:1) as the eluent afforded 14
1
crude product 11 (879.5mg, 88%), which was used in the next (269.9mg, 87%) as an oil; H-NMR (CDCl3) δ: 0.00 (9H×1/3,
1
step without further purification. An oil; H-NMR (CDCl3) δ: s), 0.03 (9H×2/3, s), 1.33–1.44 (2H, m), 1.54 (2H, s), 1.57–1.71
0.00 (9H×1/3, s), 0.02 (9H×2/3, s), 1.31–1.88 (13H, m), 1.57 (2H, m), 1.95–2.13 (2H, m), 2.06 (3H×1/3, s), 2.07 (3H×2/3,
(2H×2/3, s), 1.59 (2H×1/3, s), 1.92–2.11 (2H, m), 3.34–3.42 s), 2.42 (2H×1/3, td, J=7.2, 1.8Hz), 2.43 (2H×2/3, td, J=7.3,
(1H, m), 3.46–3.53 (1H, m), 3.68–3.90 (2H, m), 3.95 (2H×2/3, 1.8Hz), 4.40 (2H×2/3, brs), 4.51 (2H×1/3, s), 5.21 (1H×1/3,
s), 4.06 (2H×1/3, s), 4.55–4.59 (1H, m), 5.11 (1H×1/3, t, t, J=7.5Hz), 5.30 (1H×2/3, t, J=6.9Hz), 9.75 (1H×1/3, t,
J=7.5Hz), 5.29 (1H×2/3, t, J=6.8Hz).
J=1.8Hz), 9.76 (1H×2/3, t, J=1.8Hz); 13C-NMR assigned for
8-(Tetrahydro-2H-pyran-2-yl)oxy-2-(trimethylsilylmethyl)- the Z-isomer δ: −0.7 (3C), 19.3, 21.1, 21.8, 27.9, 29.0, 43.8,
oct-2-en-1-yl Acetate (12) Compound 11 (1190.3mg, 3.79mmol), 69.9, 126.0, 132.4, 170.9, 202.6. assigned for the E-isomer δ: